Search Results
Nov 06, 2025, 09:00 ET NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
researchers, clinicians, and patients, all sharing a common mission to help advance treatment and improve care for people with CCM," said Adrian L. Rabinowicz, MD, Neurelis Chief Medical Officer. "Our participation in the annual CCM meeting is particularly meaningful this year as it is the first we are sharing
More news about: Neurelis, Inc.
Nov 06, 2025, 08:37 ET Tropical Smoothie Cafe® Makes a Splash with New "Mermaid Style" Edible Blue Shimmer Sugar Topping
Fla. on Sunday, Nov. 16 and a Baltimore Ravens Purple Friday Caravan stop on Friday, Nov. 14 at 2 p.m. at the Baltimore, Md. area cafe located at 8000 Jumpers Hole Rd., Pasadena, Md. Each event will feature interactive moments and surprise rewards, with highlights shared across
More news about: Tropical Smoothie Cafe
Nov 06, 2025, 08:36 ET Arkstone's AI Clinical Decision Support Helps Treat Over 1 Million Patients
one-million-patient mark is more than a numerical milestone; it represents the individual patient lives touched and guided by our technology," said Ari Frenkel, MD, MPH, Chief Science Officer at Arkstone. "Our Antimicrobial Intelligence continues to deliver meaningful insights to providers worldwide, helping ensure
More news about: Arkstone
Nov 06, 2025, 08:14 ET Centrus Announces "At-the-Market" Equity Offering Program
BETHESDA, Md., Nov. 6, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) ("Centrus") today announced that it has entered into an at-the-market ("ATM") equity offering sales agreement
More news about: Centrus Energy Corp.
Nov 06, 2025, 08:07 ET Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients
easy-to-use diagnostic tools to help clinicians diagnose a suspected synucleinopathy, which is critical for patient care," said Christopher Gibbons, MD, FAAN, chief scientific officer and co-founder of CND and professor of Neurology at Harvard Medical School. "There are an estimated 2.5 million people
More news about: CND Life Sciences
Nov 06, 2025, 08:05 ET Sophie & Madigan's Playground Celebrates Madigan's 16th Birthday with the Sweet & Snuggly Pajama Drive
FREDERICK, Md., Nov. 6, 2025 /PRNewswire/ -- Sophie & Madigan's Playground invites the community to join in celebrating Madigan Lillard's 16th birthday by spreading warmth, kindness, and
More news about: Sophie and Madigan's Playground
Nov 06, 2025, 08:00 ET GT Medical Technologies Welcomes New GammaTile® Center of Excellence Program Designation
Michael Avery, MD, Neurosurgeon Martin Weinand, MD, Neurosurgeon Nehaw Sarmey, MD, Neurosurgeon Baldassarre Stea, MD, Radiation Oncologist Christopher Morrison, MD, Radiation Oncologist
More news about: GT Medical Technologies
Nov 06, 2025, 08:00 ET Groundbreaking Scientific Review Paper Links Air Pollution and Alzheimer's and Offers a Preventive Plan
https://alzheimersprevention.org/breaking-news/ Authored by Dharma Singh Khalsa, MD, President & Medical Director of the Alzheimer's Research and Prevention Foundation (ARPF), alongside co-authors Helen Lavretsky, MD (UCLA), Meghan Reddy, M.D. (UCLA), Annie Fenn, MD, and Christopher G. Walling, PsyD, MBA, FIPA (California
More news about: Alzheimer's Research and Prevention Foundation
Nov 06, 2025, 08:00 ET ACDi Recognized with Service Excellence Award for "Responsiveness" in Customer Satisfaction
Customers for Outstanding Support and Agility FREDERICK, Md., Nov. 6, 2025 /PRNewswire/ -- ACDi, a leading U.S.-based electronics manufacturing services (EMS) provider, today
More news about: ACDi
Nov 06, 2025, 08:00 ET Pictor Labs Expands AI Pathology Portfolio with Launch of ClearStain™ for Digital Sequencing Workflows
tissue, and accelerates turnaround times NATIONAL HARBOR, Md., Nov. 6, 2025 /PRNewswire/ -- Pictor Labs, a leader in AI-powered virtual staining and digital pathology innovation,
More news about: Pictor Labs
Nov 06, 2025, 08:00 ET OncoHost Wins 'Proteomics Innovation of the Year' at the BioTech Breakthrough Awards
for 'Proteomics Innovation of the Year,' a recognition that underscores our unwavering commitment to improving patient outcomes," said Ofer Sharon, MD, CEO of OncoHost. "This achievement reflects our dedication to rigorous scientific validation through multinational, multicenter clinical programs,
More news about: OncoHost
Nov 06, 2025, 08:00 ET Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025
R&D investor event to discuss the current treatment landscape and unmet needs in PPD. The event featured presentations by Kristina M. Deligiannidis, MD (Zucker Hillside Hospital, Northwell Health, New York) and by company management. A replay of the webinar can be accessed
More news about: Lipocine Inc.
Nov 06, 2025, 08:00 ET Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
8:30 a.m. ET GAITHERSBURG, Md., Nov. 6, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational
More news about: Novavax, Inc.
Nov 06, 2025, 07:34 ET Cannformatics to Announce Dementia and Medical Cannabis Study at the 2nd Annual New York State Medical Cannabis Symposium
Diana Martins-Welch, MD, associate professor at the Feinstein Institutes and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, specialist in hospice and palliative
More news about: Cannformatics
Nov 06, 2025, 07:27 ET MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome
urgency driving our work." "This trial represents a new era in Angelman syndrome research," said Dr. Elizabeth Berry-Kravis, MD, PhD, Professor of Pediatrics, Neurological Sciences, Anatomy and Cell Biology and Director of the RUSH Pediatric Neurosciences F.A.S.T Center for Translational
More news about: AS2Bio
Nov 06, 2025, 07:05 ET REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
at 8:00 a.m. ET ROCKVILLE, Md., Nov. 6, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today reported financial results and operational
More news about: REGENXBIO Inc.
Nov 06, 2025, 07:04 ET Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
phenotypes, offering a novel, disease-modifying small-molecule approach to obesity and T2D. Tudor Oprea, MD, PhD, Chief Executive Officer of Expert Systems Inc., highlighted the complementarity between the two companies' programs:
More news about: Mwyngil Therapeutics
Nov 06, 2025, 07:00 ET NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board
biotechnology company advancing transformative therapies for neurodegenerative and metabolic diseases, today announced that Professor Tamir Ben-Hur, MD, PhD, a renowned neurologist and long-time scientific advisor of Kadimastem Ltd., will join the Company's Scientific Advisory Board.
More news about: NewcelX Ltd.
Nov 06, 2025, 06:35 ET BCE announces renewal of Normal Course Issuer Bid for Preferred Shares
statements made in this news release, please consult BCE's 2024 Annual MD&A dated March 6, 2025, BCE's 2025 First Quarter MD&A dated May 7, 2025, BCE's 2025 Second Quarter MD&A dated August 6, 2025, BCE's 2025 Third Quarter MD&A dated November 5, 2025 and BCE's news release dated November 6,
More news about: Bell Canada (MTL)
Nov 06, 2025, 06:30 ET BCE reports third quarter 2025 results
other factors could also adversely affect our results. We encourage investors to also read BCE's 2024 Annual MD&A dated March 6, 2025 and BCE's 2025 First, Second and Third Quarter MD&As dated May 7, 2025, August 6, 2025 and November 5, 2025, respectively, for additional information with respect
More news about: Bell Canada (MTL)
Nov 06, 2025, 05:59 ET STL reports Q2 FY'26 results; driven by innovation, records strong order book growth
Connectivity Business, and Amir Sekhawat as Business Head of Enterprise Business. Ankit Agarwal, MD, STL, said, "We are entering a new phase of global growth, powered by innovation and partnerships. We are extensively engaging
More news about: Sterlite Technologies Ltd - STL
Nov 06, 2025, 04:04 ET Netcore Unbxd Launches 'Enrichment for Agentic Commerce' to Make Retailers Visible in the Age of AI Shopping
"If search was about SEO, agentic commerce is about data quality," said Rajesh Jain, Founder and Group MD, Netcore Cloud. "Retailers today are invisible to AI unless their data is structured, semantic, and ACP-ready. With Enrichment for Agentic Commerce,
More news about: Netcore Cloud
Nov 05, 2025, 21:31 ET Prevent Blindness Declares Sixth Annual Thyroid Eye Disease (TED) Week to Educate Public on Condition That Can Threaten Sight and Mental Wellness
TED Community Organization; Prem Subramanian, MD, PhD, Clifford R. and Janice N. Merrill Endowed Chair in Ophthalmology and Vice Chair for Academic Affairs at
More news about: Prevent Blindness
Nov 05, 2025, 17:46 ET The Michael J. Fox Foundation for Parkinson's Research Applauds Texas Voters on Passage of Proposition 14 Securing $3 Billion for Brain Disease Research
for loved ones who also face this disease, I've seen how powerful it is when our community comes together to push for change," said María L. De León, MD, an East Texas resident, movement disorder specialist and member of MJFF's Patient Council. "The passage of Proposition 14 proves that collective advocacy
More news about: The Michael J. Fox Foundation for Parkinson's Research
Nov 05, 2025, 17:04 ET Centrus Reports Third Quarter 2025 Results
of planned expansion of enrichment plant BETHESDA, Md., Nov. 5, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) ("Centrus" or the "Company") today reported
More news about: Centrus Energy Corp.